You’ve probably read the headline: Under MDUFA 2012, the FDA’s user fees will more than double. But the law does much more than that. It makes major changes to the way the agency regulates devicemakers – touching on everything from approvals to inspections.

You could spend days or even weeks reading and digesting the regulatory changes devicemakers face under the new MDUFA law – changes that may upend the way you do business. Or you can let us do that work for you.

Order Today

Each time it’s reauthorized, the MDUFA law lays out a long list of marching orders for the FDA to follow in developing new regulations for devicemakers. This year, the list includes:

• New authorizations for the FDA to enter into agreements with foreign countries to harmonize requirements and share inspections data
• Revised requirements for “de novo” determinations
• Provisions to allow the director of CDRH, in consultation with the FDA  Commissioner, to administratively reclassify some devices 
• Details on the long awaited Unique Device Identifier proposed regulations
• New incentives to encourage testing of medical products in pediatric patients
• A new definition of the ‘least burdensome’ provisions applied to PMA and 510(k) applications
• The impact of the revised recall audit requirements
• Clarification of FDA policy on custom medical devices
• New guidelines on how the FDA will calculate its decision deadlines
• Procedures and mandates for scheduling meetings with the FDA when an application falls behind
• A congressional directive that the FDA audit its entire device review process
• And more.

Don’t waste countless hours researching all the changes MDUFA has in store for your business. We’ve done the work for you with MDUFA 2012: A Devicemaker’s Guide to New Provisions in the Law.

Buy Now!
MDUFA 2012: A Devicemaker’s Guide to New Provisions in the Law is available in print or PDF formats for $377 each.

Satisfaction Guaranteed
There's no risk when you purchase from FDAnews with our money-back guarantee. Not satisfied with your publication? Return the hard copy within 30 days (in resalable condition), and we will refund 100 percent of your purchase price (less shipping/handling). For the PDF version, you must notify FDAnews within 24 hours of receipt of purchase to receive a refund.